Sarepta Therapeutics CEO Chris Garabedian resigns By: MarketWatch April 01, 2015 at 08:54 AM EDT Biotech’s Chief Marketing Officer Edward Kaye will take over as interim CEO. Read More >> Related Stocks: Sarepta Therapeutics